Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI® induces enhanced serological, cellular and protective immune responses

• Main Authors: Weiping Cao (Author), Margarita Mishina (Author), Samuel Amoah (Author), Wadzanai P. Mboko (Author), Caitlin Bohannon (Author), James McCoy (Author), Suresh K. Mittal (Author), Shivaprakash Gangappa (Author), Suryaprakash Sambhara (Author)
• Format: Book
• Published: Taylor & Francis Group, 2018-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Avian influenza virus infection is a serious public health threat and preventive vaccination is the most cost-effective public health intervention strategy. Unfortunately, currently available unadjuvanted avian influenza vaccines are poorly immunogenic and alternative vaccine formulations and delive...